Tolazoline

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C10H12N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CHH9H12AQ3, chemically known as 4,5-dihydro-2-(phenylmethyl)-1h-imidazole but generally known as tolazoline, which bears US NIH Compound Identifier 5504. European Medicines Agency schedules Tolazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11148MIG. The term TOLAZOLINE is an International Non-Proprietary Name. World Health Organization schedules tolazoline in its Anatomical Therapeutic Chemical (ATC) Classification. TOLAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tolazoline under HS 29332990 and SITC 51573. As of Q4 2014, TOLAZOLINE remains the US FDA Preferred Term for this commodity. Tolazoline bears US NLM identifiers UMLS ID C0040373 and NCI Concept Code C66608. SMILES: C1CN=C(N1)CC2=CC=CC=C2.